Saturday, June 20, 2026

Elon Musk Dances His Way to Victory at Tesla Shareholder Meeting!

WSJ reported that Tesla CEO Elon Musk celebrated his victory in a wage vote by dancing on the stage of the general meeting.

The Bay of Pigs Invasion: How CIA’s 1961 Blunder Shaped U.S.-Cuba Relations

The Bay of Pigs invasion in 1961 highlights U.S. foreign policy failures, leading to Castro's power consolidation and Cold War tensions.

“CEMENT IS OUR AMMO” Kim Jong Un Forces 115% Production While Citizens Starve for Bread

North Korea's Sangwon Cement Complex has achieved 115% daily production, highlighting its role in national construction and technological advancements.

Tag: GC Cell

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

GC Cell Secures Japanese Certification for the Manufacture of Specific Cell Processing Products

GC Cell receives final certification from Japan for cell processing products, validating its manufacturing and quality systems for regenerative medicine.

GC Cell Showcases Cold Chain Innovations the Spring Symposium of the Korean Society of Laboratory Medicine

GC Cell, GC Green Cross, and GC Genome showcased innovations in diagnostics at the 2023 Spring Symposium, enhancing precision medicine.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

GCC2005: The Breakthrough CAR-NK Therapy for T-Cell Lymphoma Unveiled at TCLF 2026

GC Cell presents promising CD5-targeting CAR-NK therapy GCC2005 for T-cell lymphoma, showing significant efficacy and safety at TCLF.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.